|
1
|
Broadhead ML, Clark JC, Myers DE, Dass CR
and Choong PF: The molecular pathogenesis of osteosarcoma: A
review. Sarcoma. 2011:9592482011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hameed M and Dorfman H: Primary malignant
bone tumors - recent developments. Semin Diagn Pathol. 28:86–101.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kobayashi E, Hornicek FJ and Duan Z:
MicroRNA involvement in osteosarcoma. Sarcoma. 2012:3597392012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weeden S, Grimer RJ, Cannon SR, Taminiau
AH and Uscinska BM: The effect of local recurrence on survival in
resected osteosarcoma. Eur J Cancer. 37:39–46. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Harting MT, Blakely ML, Jaffe N, Cox CS
Jr, Hayes-Jordan A, Benjamin RS, Raymond AK, Andrassy RJ and Lally
KP: Long-term survival after aggressive resection of pulmonary
metastases among children and adolescents with osteosarcoma. J
Pediatr Surg. 41:194–199. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schrauder MG, Strick R, Schulz-Wendtland
R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A,
Hein A, et al: Circulating micro-RNAs as potential blood-based
markers for early stage breast cancer detection. PLoS One.
7:e297702012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Soifer HS, Rossi JJ and Saetrom P:
MicroRNAs in disease and potential therapeutic applications. Mol
Ther. 15:2070–2079. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma R, Jiang T and Kang X: Circulating
microRNAs in cancer: Origin, function and application. J Exp Clin
Cancer Res. 31:382012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kosaka N, Iguchi H and Ochiya T:
Circulating microRNA in body fluid: A new potential biomarker for
cancer diagnosis and prognosis. Cancer Sci. 101:2087–2092. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lawrie CH, Gal S, Dunlop HM, et al:
Detection of elevated levels of tumour-associated microRNAs in
serum of patients with diffuse large B-cell lymphoma. Br J
Haematol. 141:672–675. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zeng X, Xiang J, Wu M, Xiong W, Tang H,
Deng M, Li X, Liao Q, Su B, Luo Z, et al: Circulating miR-17,
miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers
in nasopharyngeal carcinoma. PLoS One. 7:e463672012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Q, Li P, Li A, Jiang W, Wang H, Wang
J and Xie K: Plasma specific miRNAs as predictive biomarkers for
diagnosis and prognosis of glioma. J Exp Clin Cancer Res.
31:972012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ng EK, Li R, Shin VY, Jin HC, Leung CP, Ma
ES, Pang R, Chua D, Chu KM, Law WL, et al: Circulating microRNAs as
specific biomarkers for breast cancer detection. PLoS One.
8:e531412013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Si H, Sun X, Chen Y, Cao Y, Chen S, Wang H
and Hu C: Circulating microRNA-92a and microRNA-21 as novel
minimally invasive biomarkers for primary breast cancer. J Cancer
Res Clin Oncol. 139:223–229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li C, Li JF, Cai Q, Qiu QQ, Yan M, Liu BY
and Zhu ZG: MiRNA-199a-3p: A potential circulating diagnostic
biomarker for early gastric cancer. J Surg Oncol. 108:89–92. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Valladares-Ayerbes M, Reboredo M,
Medina-Villaamil V, Iglesias-Díaz P, Lorenzo-Patiño MJ, Haz M,
Santamarina I, Blanco M, Fernández-Tajes J, Quindós M, et al:
Circulating miR-200c as a diagnostic and prognostic biomarker for
gastric cancer. J Transl Med. 10:1862012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sita-Lumsden A, Dart DA, Waxman J and
Bevan CL: Circulating microRNAs as potential new biomarkers for
prostate cancer. Br J Cancer. 108:1925–1930. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Morimura R, Komatsu S, Ichikawa D,
Takeshita H, Tsujiura M, Nagata H, Konishi H, Shiozaki A, Ikoma H,
Okamoto K, et al: Novel diagnostic value of circulating miR-18a in
plasma of patients with pancreatic cancer. Br J Cancer.
105:1733–1740. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Menéndez P, Padilla D, Villarejo P,
Palomino T, Nieto P, Menéndez JM and Rodríguez-Montes JA:
Prognostic implications of serum microRNA-21 in colorectal cancer.
J Surg Oncol. 108:369–373. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fox MG and Trotta BM: Osteosarcoma: Review
of the various types with emphasis on recent advancements in
imaging. Semin Musculoskelet Radiol. 17:123–136. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu H, Zhang Y, Cai XH, Huang JF and Cai L:
Changes in microRNA expression in the MG-63 osteosarcoma cell line
compared with osteoblasts. Oncol Lett. 4:1037–1042. 2012.PubMed/NCBI
|
|
26
|
Jones KB, Salah Z, Del Mare S, Galasso M,
Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, et
al: miRNA signatures associate with pathogenesis and progression of
osteosarcoma. Cancer Res. 72:1865–1877. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao G, Cai C, Yang T, Qiu X, Liao B, Li
W, Ji Z, Zhao J, Zhao H, Guo M, et al: MicroRNA-221 induces cell
survival and cisplatin resistance through PI3K/Akt pathway in human
osteosarcoma. PLoS One. 8:e539062013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shen L, Chen XD and Zhang YH: MicroRNA-128
promotes proliferation in osteosarcoma cells by downregulating
PTEN. Tumour Biol. 35:2069–2074. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Zhao W and Fu Q: miR-335
suppresses migration and invasion by targeting ROCK1 in
osteosarcoma cells. Mol Cell Biochem. 384:105–111. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou X, Wei M and Wang W: MicroRNA-340
suppresses osteosarcoma tumor growth and metastasis by directly
targeting ROCK1. Biochem Biophys Res Commun. 437:653–658. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu JQ, Liu P, Si MJ and Ding XY:
MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting
Sirt1. Tumour Biol. 34:3871–3877. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu LH, Li H, Li JP, Zhong H, Zhang HC,
Chen J and Xiao T: miR-125b suppresses the proliferation and
migration of osteosarcoma cells through down-regulation of STAT3.
Biochem Biophys Res Commun. 416:31–38. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dai DW, Lu Q, Wang LX, Zhao WY, Cao YQ, Li
YN, Han GS, Liu JM and Yue ZJ: Decreased miR-106a inhibits glioma
cell glucose uptake and proliferation by targeting SLC2A3 in GBM.
BMC Cancer. 13:4782013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Díaz R, Silva J, García JM, Lorenzo Y,
García V, Peña C, Rodríguez R, Muñoz C, García F, Bonilla F and
Domínguez G: Deregulated expression of miR-106a predicts survival
in human colon cancer patients. Genes Chromosomes Cancer.
47:794–802. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhi F, Zhou G, Shao N, Xia X, Shi Y, Wang
Q, Zhang Y, Wang R, Xue L, Wang S, et al: miR-106a-5p inhibits the
proliferation and migration of astrocytoma cells and promotes
apoptosis by targeting FASTK. PLoS One. 8:e723902013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fan MQ, Huang CB, Gu Y, Xiao Y, Sheng JX
and Zhong L: Decrease expression of microRNA-20a promotes cancer
cell proliferation and predicts poor survival of hepatocellular
carcinoma. J Exp Clin Cancer Res. 32:212013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Di Leva G, Piovan C, Gasparini P, Ngankeu
A, Taccioli C, Briskin D, Cheung DG, Bolon B, Anderlucci L, Alder
H, et al: Estrogen mediated-activation of miR-191/425 cluster
modulates tumorigenicity of breast cancer cells depending on
estrogen receptor status. PLoS Genet. 9:e10033112013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen L, Wang Q, Wang GD, Wang HS, Huang Y,
Liu XM and Cai XH: miR-16 inhibits cell proliferation by targeting
IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma. FEBS
Lett. 587:1366–1372. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu N, Jiang N, Guo R, Jiang W, He QM, Xu
YF, Li YQ, Tang LL, Mao YP, Sun Y and Ma J: MiR-451 inhibits cell
growth and invasion by targeting MIF and is associated with
survival in nasopharyngeal carcinoma. Mol Cancer. 12:1232013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li HY, Zhang Y, Cai JH and Bian HL:
MicroRNA-451 inhibits growth of human colorectal carcinoma cells
via downregulation of Pi3k/Akt pathway. Asian Pac J Cancer Prev.
14:3631–3634. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bian HB, Pan X, Yang JS, Wang ZX and De W:
Upregulation of microRNA-451 increases cisplatin sensitivity of
non-small cell lung cancer cell line (A549). J Exp Clin Cancer Res.
30:202011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Redova M, Poprach A, Nekvindova J, Iliev
R, Radova L, Lakomy R, Svoboda M, Vyzula R and Slaby O: Circulating
miR-378 and miR-451 in serum are potential biomarkers for renal
cell carcinoma. J Transl Med. 10:552012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bandres E, Bitarte N, Arias F, Agorreta J,
Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ,
et al: MicroRNA-451 regulates macrophage migration inhibitory
factor production and proliferation of gastrointestinal cancer
cells. Clin Cancer Res. 15:2281–2290. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li Q, Zou C, Zou C, Han Z, Xiao H, Wei H,
Wang W, Zhang L, Zhang X, Tang Q, et al: MicroRNA-25 functions as a
potential tumor suppressor in colon cancer by targeting Smad7.
Cancer Lett. 335:168–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Esposito F, Tornincasa M, Pallante P,
Federico A, Borbone E, Pierantoni GM and Fusco A: Down-regulation
of the miR-25 and miR-30d contributes to the development of
anaplastic thyroid carcinoma targeting the polycomb protein EZH2. J
Clin Endocrinol Metab. 97:E710–E718. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hiroki E, Akahira J, Suzuki F, Nagase S,
Ito K, Suzuki T, Sasano H and Yaegashi N: Changes in microRNA
expression levels correlate with clinicopathological features and
prognoses in endometrial serous adenocarcinomas. Cancer Sci.
101:241–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Krishnan K, Steptoe AL, Martin HC,
Pattabiraman DR, Nones K, Waddell N, Mariasegaram M, Simpson PT,
Lakhani SR, Vlassov A, et al: miR-139-5p is a regulator of
metastatic pathways in breast cancer. RNA. 19:1767–1780. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li RY, Chen LC, Zhang HY, Du WZ, Feng Y,
Wang HB, Wen JQ, Liu X, Li XF, Sun Y, et al: MiR-139 inhibits Mcl-1
expression and potentiates TMZ-induced apoptosis in glioma. CNS
Neurosci Ther. 19:477–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ratert N, Meyer HA, Jung M, Lioudmer P,
Mollenkopf HJ, Wagner I, Miller K, Kilic E, Erbersdobler A, Weikert
S and Jung K: miRNA profiling identifies candidate miRNAs for
bladder cancer diagnosis and clinical outcome. J Mol Diagn.
15:695–705. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sand M, Skrygan M, Sand D, Georgas D, Hahn
SA, Gambichler T, Altmeyer P and Bechara FG: Expression of
microRNAs in basal cell carcinoma. Br J Dermatol. 167:847–855.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang M, Liu R, Sheng J, Liao J, Wang Y,
Pan E, Guo W, Pu Y and Yin L: Differential expression profiles of
microRNAs as potential biomarkers for the early diagnosis of
esophageal squamous cell carcinoma. Oncol Rep. 29:169–176.
2013.PubMed/NCBI
|
|
52
|
Kim BH, Hong SW, Kim A, Choi SH and Yoon
SO: Prognostic implications for high expression of oncogenic
microRNAs in advanced gastric carcinoma. J Surg Oncol. 107:505–510.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Liu Z, Gersbach E, Zhang X, Xu X, Dong R,
Lee P, Liu J, Kong B, Shao C and Wei JJ: miR-106a represses the Rb
tumor suppressor p130 to regulate cellular proliferation and
differentiation in high-grade serous ovarian carcinoma. Mol Cancer
Res. 11:1314–1325. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Huang G, Nishimoto K, Zhou Z, Hughes D and
Kleinerman ES: miR-20a encoded by the miR-17-92 cluster increases
the metastatic potential of osteosarcoma cells by regulating Fas
expression. Cancer Res. 72:908–916. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Hummel R, Wang T, Watson DI, Michael MZ,
Van der Hoek M, Haier J and Hussey DJ: Chemotherapy-induced
modification of microRNA expression in esophageal cancer. Oncol
Rep. 26:1011–1017. 2011.PubMed/NCBI
|
|
57
|
Zhang H, Zuo Z, Lu X, Wang L, Wang H and
Zhu Z: MiR-25 regulates apoptosis by targeting Bim in human ovarian
cancer. Oncol Rep. 27:594–598. 2012.PubMed/NCBI
|
|
58
|
Zhao H, Wang Y, Yang L, Jiang R and Li W:
MiR-25 promotes gastric cancer cells growth and motility by
targeting RECK. Mol Cell Biochem. 385:207–213. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Xu X, Chen Z, Zhao X, Wang J, Ding D, Wang
Z, Tan F, Tan X, Zhou F, Sun J, et al: MicroRNA-25 promotes cell
migration and invasion in esophageal squamous cell carcinoma.
Biochem Biophys Res Commun. 421:640–645. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Cookson VJ, Bentley MA, Hogan BV, Horgan
K, Hayward BE, Hazelwood LD and Hughes TA: Circulating microRNA
profiles reflect the presence of breast tumours but not the
profiles of microRNAs within the tumours. Cell Oncol (Dordr).
35:301–308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Boeri M, Verri C, Conte D, Roz L, Modena
P, Facchinetti F, Calabrò E, Croce CM, Pastorino U and Sozzi G:
MicroRNA signatures in tissues and plasma predict development and
prognosis of computed tomography detected lung cancer. Proc Natl
Acad Sci USA. 108:3713–3718. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Brase JC, Wuttig D, Kuner R and Sültmann
H: Serum microRNAs as non-invasive biomarkers for cancer. Mol
Cancer. 9:3062010. View Article : Google Scholar : PubMed/NCBI
|
